Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues

Clinical Cancer Research

Volumn 7, Issue 6, 2001, Pages 1706-1715

  Das, Rina ^a   Hammamieh, Rasha ^a   Neill, Roger ^a   Melhem, Mona ^b,c   Jett, Marti ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; FATTY ACID BINDING PROTEIN;

ADIPOSE TISSUE; ARTICLE; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE; LIVER; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BIOPSY; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIVISION; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FATTY ACID-BINDING PROTEINS; HUMANS; MALE; MYELIN SHEATH; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0034896267     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fat and prostate cancer
2. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase
3. A prospective study of dietary fat and risk of prostate cancer
4. Effects of fatty acids and eiconsanoid synthesis inhibitors on the growth of two human prostate cancer cell lines
5. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet
6. The influence of soluble binding proteins on lipophile transport and metabolism in hepatocytes
7. The cellular fatty acid binding proteins: Aspects of structure, regulation and function
8. Structural and functional studies on different human FABP types
9. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein
10. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model
11. Towards a comprehensive database of proteins from the urine of patients with bladder cancer
12. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins
13. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes
14. Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen
15. Liver fatty acid-binding protein: Specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators
16. Purification, biological assay and immunoassay of mammary-derived growth inhibitor
17. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes
18. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas
19. Purification and characterization of a fatty acid binding protein from human prostatic tissue
20. Transduction of prolactin's growth signal through both long and short forms of the prolactin receptor
21. Classification of prostatic carcinomas
22. Histologic grade, clinical stage, and patient age in prostate cancer
23. Histologic grading of prostate cancer: A perspective
24. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer
25. Decreased galectin-3 expression in prostate cancer
26. Eicosanoid regulation of angiogenesis in human prostate carcinoma and its therapeutic implications
27. Expression, purification, and crystal structure determination of recombinant human epidermal-type fatty acid binding protein
28. Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver
29. POU transcription factors control expression of CNS stem cell-specific genes
30. Primary structure and binding characteristics of locust and human muscle fatty-acid-binding proteins
31. Modulation of fatty-acid-binding protein content of rat heart and skeletal muscle by endurance training and testosterone treatment
32. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein
33. Liver fatty acid binding protein enhances sterol transfer by membrane interaction
34. 9-cis-retinoic acid enhances fatty acid-induced expression of the liver fatty acid-binding protein gene
35. Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation
36. Isolation of a unique melanogenic inhibitor from human skin xenografts: Initial in vitro and in vivo characterization
37. Protein abundancy and mRNA levels of the adipocyte-type fatty acid binding protein correlate in noninvasive and invasive bladder transitional cell carcinomas
38. Fatty acid metabolism in human breast cancer cells (MCF7) transfected with heart-type fatty acid binding protein
39. Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake
40. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer